What Is Going on with Apple Stock on Wednesday?
Apple stock dips despite launching M6 Mac mini and M5 Studio desktops as analysts highlight on-device AI capabilities and the upcoming Duo foldable launch.
Stocks · News reference
Recent Filing Shows That Rep. Pete Sessions Sold Over $100K Worth of Apple Stock
A September filing shows that Representative Pete Sessions reported a sale in Apple (NASDAQ:AAPL), valued between $100,001 and $250,000. The transaction date is listed as September 22, 2026, with the report published on
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
EXCLUSIVE: AI Data Center Boom Is ‘Overkill,’ Defense AI CEO Warns Compute Demand Will Drop
Defense AI CEO Tyler Saltsman says smaller local models could cut cloud compute demand as data-center spending surges.
Prediction: This ETF Could Make You a Millionaire With Just $750 per Month
The Vanguard Morningstar Growth ETF (VUG) could help investors reach millionaire status through consistent monthly investments of $750 over 25 years, based on its historical 11% average annual returns. The ETF focuses on large-cap growth stocks with heavy concentration in tech companies like Nvidia, Apple, and Microsoft, which have benefited from the AI boom but also carry concentration risk.
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH
The Invesco Nasdaq Biotechnology ETF (IBBQ) offers lower costs (0.19% expense ratio) and higher 1-year returns (44.6%), making it suitable for growth-focused investors willing to accept volatility. The iShares U.S. Healthcare ETF (IYH) provides broader diversification across 100 healthcare holdings with higher dividend yield (1.1%) and lower volatility, appealing to conservative investors seeking stability and income.
Congressman with $11.5 Million in Trades Keeps Selling Stocks: Here’s the Latest Moves
A member of Congress continues to sell stocks, with no buys since 2024. Here are the latest names traded.
Cerebras Systems vs. Rigetti Computing: Is an AI or Quantum Computing Stock the Better Buy in 2026?
Cerebras Systems and Rigetti Computing represent two different computing frontiers. Cerebras dominates AI hardware with $510M in revenue and 76% growth, while Rigetti pursues quantum computing with only $7.1M in revenue but significant government backing. The article recommends Cerebras as the better 2026 buy due to its established business base, clear growth trajectory, and more reasonable valuation despite both stocks being speculative.